Dysport
Manufacturing · Alabama, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1419 Hamric Dr E Ste 101, Oxford, Alabam...Phone Number
(256) 235-3663Website
www.dysport.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dysport
Ipsen Biopharmaceuticals Inc. offers Dysport® (abobotulinumtoxinA), a prescription medication used to treat increased muscle stiffness in children aged 2 years and older with spasticity, as well as adults with cervical dystonia. The company provides resources for patients and caregivers, including an injector locator to find trained specialists. Dysport is designed to provide lasting symptom relief, with specific treatment intervals for various conditions. Ipsen emphasizes the importance of safety information and encourages communication with healthcare professionals regarding potential side effects.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dysport your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Dysport
Check if Dysport has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Dysport recently announced quarterly report
Click to see if Dysport had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Dysport has new funding data
Check out if Dysport is spiking on competitors!
Website visits: Recent activity has been detected on your website
Dysport, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Dysport launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Dysport
Compare insights from companies similar to Dysport, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dysport
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Dysport is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dysport is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dysport.
Dysport Tech Stack
A closer look at the technologies used by Dysport
See more technologies
Dysport News & Media
Ipsen Delivers Strong Sales Growth of 20.2%1 for the Third Quarter of 2018 and Confirms Full Year Guidance
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter of 2018. Financial highlights Q3 2018 Group sales growth of 20.2%1 driven by Specialty Care sales growth of 24.2%1 reflecting strong momentum for Somatuline® and Dysport®, continued sequential sales growth for Cabometyx® and Onivyde®, and growth of Consumer Healthcare sales of 5.0%2 YTD Group sales growth of 21.1%1 fueled by sIpsen Delivers Strong Results for the First Half of 2018 with Sales Growth of 21.5%1 and Upgrades Its Guidance for Full Year 2018
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced financial results for the first half of 2018. H1 2018 Key figures (in millions of euros) H1 2018 H1 2017 % change Group sales 1,064.5 919.5 +21.5%1 Specialty Care sales 920.2 764.6 +26.7%1 Consumer Healthcare sales 144.3 154.8 +2.0%1,2 Core Operating Income3 322.5
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Dysport
Sign Up For FreeTo access detailed company insights
Ipsen Biopharmaceuticals Inc. offers Dysport® (abobotulinumtoxinA), a prescription medication used to treat increased muscle stiffness in children aged 2 years and older with spasticity, as well as adults with cervical dystonia. The company provides resources for patients and caregivers, including an injector locator to find trained specialists. Dy... Read More
